you are here: HomeNewsTrendsHealth

Mysuru reports first case of Delta Plus variant of COVID-19 in Karnataka

The minister said the state government is carefully monitoring the emergence of new variants and it has decided to set up six genome labs in the state.

June 23, 2021 / 02:02 PM IST

Mysuru has reported the first case of Delta Plus variant of COVID-19 in Karnataka, and the infected person is asymptomatic and none of his contacts have contracted the virus, Health Minister K Sudhakar said on Wednesday.

"In Mysuru, one patient is infected with Delta Plus variant, whom we have isolated but he is asymptomatic and none of his primary and secondary contacts have it. That is a good sign," Sudhakar told reporters.

Also Read: Explained | Why coronavirus’ Delta Plus variant is concerning

Also Read: India designates Delta Plus a ‘Variant of Concern’; Maharashtra, Kerala, MP told to ramp up containment measures

The minister said the state government is carefully monitoring the emergence of new variants and it has decided to set up six genome labs in the state.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

"Wherever we have suspicion, we are doing genomic sequencing. We are doing random checks of five per cent of the total samples checked," Sudhakar said.

According to Sudhakar, Karnataka is conducting about 1.5 lakh to two lakh COVID-19 tests daily. He said the government is sending vaccines to all the districts wherever there is suspicion of Delta Plus sequencing.

On the preparedness to deal with the third COVID wave, which is believed to affect children, Sudhakar said preparations are afoot to set up paediatric wards with ICU, and appoint doctors and nurses within 45 days in all the districts.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Jun 23, 2021 02:02 pm

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark